DOI QR코드

DOI QR Code

Merging the old with the new: a cybermedicine marriage for oncology interactions with traditional herbal therapies and complementary medicines

  • Yap, Kevin Yi-Lwern (Institute of Digital Healthcare, WMG, University of Warwick, International Digital Laboratory) ;
  • Lim, Ken Juin (Department of Pharmacy, Faculty of Science, National University of Singapore)
  • Received : 2012.01.20
  • Accepted : 2012.05.22
  • Published : 2012.05.31

Abstract

An oncology-specific database called OncoRx (http://bit.ly/cancerRx) was previously set up in cyberspace to aid clinicians in identifying interactions of anticancer drugs (ACDs) and chemotherapy regimens with traditional Chinese medicines (TCMs) and complementary and alternative medicines (CAMs). Since then, users have requested the drug-CAM interactions (DCIs) of 5 specific CAMs (cranberry, melatonin, co-enzyme Q10, huachansu, reishi mushroom) to be updated in the database. Pharmacokinetic properties (metabolism, enzyme induction/inhibition, elimination), TCM properties and DCIs of each CAM were collated with 117 ACDs using 9 hardcopy compendia and online databases as resources. Additionally, individual ACDs and CAMs were used as keywords for PubMed searches in combination with the terms 'anticancer drugs', 'drug interactions', 'herb-drug/drug-herb interactions', 'pharmacokinetic interactions' and 'pharmacodynamic interactions'. DCI parameters consisted of interaction effects, evidence summaries, proposed management plans and alternative non-interacting CAMs, together with relevant citations and update dates of the DCIs. OncoRx is also used as a case to introduce the "Four Pharmaco-cybernetic Maxims" of quality, quantity, relationship and manner to developers of digital healthcare tools. Its role in Hayne's "5S" hierarchy of research evidence is also presented. OncoRx is meant to complement existing DCI resources for clinicians and alternative medicine practitioners as an additional drug information resource that provides evidence-based DCI information for ACD-CAM interactions.

Keywords

References

  1. Ahmadi K, Riazipour M. Effect of Ganoderma lucidum on cytokine release by peritoneal macrophages. Iran J Immunol. 2007;4(4):220-226.
  2. Baker L, Wagner TH, Singer S, Bundorf MK. Use of the internet and e-mail for health care information: results from a national survey. JAMA. 2003;289:2400-2406. https://doi.org/10.1001/jama.289.18.2400
  3. Belardinelli R, Mucaj A, Lacalaprice F, Solenghi M, Seddaiu G, Principi F, Tiano L, Littarru GP. Coenzyme Q10 and exercise training in chronic heart failure. Eur Heart J. 2006;27(22):2675-2681. https://doi.org/10.1093/eurheartj/ehl158
  4. Boles RG, Lovett-Barr MR, Preston A, Li BU, Adams K. Treatment of cyclic vomiting syndrome with co-enzyme Q10 and amitriptyline, a retrospective study. BMC Neurol. 2010;10:10. https://doi.org/10.1186/1471-2377-10-10
  5. Bristol-Myers Squibb Co. Ixempra (ixabepilone) for injection [product information]. Princeton, NJ; 2010.
  6. British Medical Association, Pharmaceutical Society of Great Britain. British National Formulary. 53rd Ed (London, UK: BMJ Publishing Group Ltd & RPS Publishing), 2007.
  7. Brzezinski A. Melatonin in humans. N Engl J Med. 1997;336(3):186-195. https://doi.org/10.1056/NEJM199701163360306
  8. Cao LZ, Lin ZB. Comparison of the effects of polysaccharides from wood-cultured and bag-cultured Ganoderma lucidum on murine spleen lymphocyte proliferation in vitro. Yao Xue Xue Bao. 2003;38(2):92-97.
  9. Caroleo MC, Frasca D, Nistico G, Doria G. Melatonin as immunomodulator in immunodeficient mice. Immunopharmacology. 1992;23(2):81-89. https://doi.org/10.1016/0162-3109(92)90031-7
  10. Chan A, Yap KY-L, Tan SH, Low XH. Efficacy of antiemetics in patients receiving XELOX - A single-centre, prospective study. EJC supplements. 2011;9(1):17.
  11. Chang L-C, Li I-C. Patterns of complementary therapy use by homebound cancer patients in Taiwan. Appl Nurs Res. 2004;17(1):41-47. https://doi.org/10.1016/j.apnr.2003.10.006
  12. Chen HS, Tsai YF, Lin S, Lin CC, Khoo KH, Lin CH, Wong CH. Studies on the immuno-modulating and anti-tumor activities of Ganoderma lucidum (Reishi) polysaccharides. Bioorg Med Chem. 2004;12(21):5595-5601. https://doi.org/10.1016/j.bmc.2004.08.003
  13. Chen NH, Liu JW, Zhong JJ. Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression. J Pharmacol Sci. 2008;108(2):212-216. https://doi.org/10.1254/jphs.SC0080019
  14. Chow WH, Chang P, Lee SC, Wong A, Shen HM, Verkooijen HM. Complementary and alternative medicine among Singapore cancer patients. Ann Acad Med Singapore. 2010;39(2):129-135.
  15. Clarke SJ, McLachlan AJ, Brown D, Carbonara S, Kissane R. Beyond conventional cancer treatments: The use of complementary therapies during cancer treatment: Implications for clinicians. In When Cancer Crosses Disciplines: A Physician's Handbook, Robotin M, Olver I, Girgis A eds. (London, UK: Imperial College Press), pp. 285-316, 2010.
  16. Combs AB, Choe JY, Truong DH, Folkers K. Reduction by coenzyme Q10 of the acute toxicity of adriamycin in mice. Res Commun Chem Pathol Pharmacol. 1977;18(3):565-568.
  17. Conklin KA. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr Cancer Ther. 2005;4(2):110-130. https://doi.org/10.1177/1534735405276191
  18. DiGianni LM, Garber JE, Winer EP. Complementary and alternative medicine use among women with breast cancer. J Clin Oncol. 2002;20(18):34s-38s.
  19. e-MS Inc. TCM Assistant. http://www.tcmassistant.com/index.html. Accessed 10 January 2011.
  20. Ferguson PJ, Kurowska E, Freeman DJ, Chambers AF, Koropatnick DJ. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J Nutr. 2004;134(6):1529-1535. https://doi.org/10.1093/jn/134.6.1529
  21. Ferguson PJ, Kurowska EM, Freeman DJ, Chambers AF, Koropatnick J. In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract. Nutr Cancer. 2006;56(1):86-94. https://doi.org/10.1207/s15327914nc5601_12
  22. Fua LN, Beh J, Sen VA. Oncology drug database greatly benefits elderly cancer patients. NUS Knowledge Enterprise. 2011;11(3):6.
  23. Gao L, Wu X. Comparison of traditional Chinese medicine with Western medicine cancer therapy. Chinese J Clin Oncol. 2008;5(3):231-234. https://doi.org/10.1007/s11805-008-0231-z
  24. Gao Y, Dai X, Chen G, Ye J, Zhou S. A randomized, placebo-controlled, multicenter study of Ganoderma lucidum (W.Curt.:Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly) in patients with advanced lung cancer. Int J Med Mushrooms. 2003a;5(4):49-62. https://doi.org/10.1615/InterJMedicMush.v5.i1.70
  25. Gao Y, Zhou S, Chen G, Dai X, Ye J. A phase I/II study of a Ganoderma lucidum (Curt.: Fr.) P. Karst. extract (Ganopofy) in patients with advanced cancer. Int J Med Mushrooms. 2002;4(3):21-28.
  26. Gao Y, Zhou S, Jiang W, Huang M, Dai X. Effects of ganopoly (a Ganoderma lucidum polysaccharide extract) on the immune functions in advanced-stage cancer patients. Immunol Invest. 2003b;32(3):201-215. https://doi.org/10.1081/IMM-120022979
  27. Gerstner Jr. LV. Memorial Sloan-Kettering Cancer Center - cancer information (about herbs, botanicals and other products). http://www.mskcc.org/mskcc/html/11570.cfm. Accessed 10 January 2011.
  28. Gonzalez A, Alvarez-Garcia V, Martinez-Campa C, Mediavilla MD, Alonso-Gonzalez C, Sanchez-Barcelo EJ, Cos S. In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin. Curr Cancer Drug Targets. 2010;10(3):279-286. https://doi.org/10.2174/156800910791190201
  29. Grant P. Warfarin and cranberry juice: an interaction? J Heart Valve Dis. 2004;13(1):25-26.
  30. Greenberg S, Frishman WH. Co-enzyme Q10: a new drug for cardiovascular disease. J Clin Pharmacol. 1990;30(7):596-608. https://doi.org/10.1002/j.1552-4604.1990.tb01862.x
  31. Greenblatt DJ, von Moltke LL, Perloff ES, Luo Y, Harmatz JS, Zinny MA. Interaction of flurbiprofen with cranberry juice, grape juice, tea, and fluconazole: in vitro and clinical studies. Clin Pharmacol Ther. 2006;79(1):125-133. https://doi.org/10.1016/j.clpt.2005.09.014
  32. Griffiths AP, Beddall A, Pegler S. Fatal haemopericardium and gastrointestinal haemorrhage due to possible interaction of cranberry juice with warfarin. J R Soc Promot Health. 2008;128(6):324-326. https://doi.org/10.1177/1466424008096615
  33. Gruenwald J, Brendler T, Jaenicke C eds. Physicians' Desk Reference (PDR) for Herbal Medicines. 4th Ed (Montvale, NJ: Thomson Healthcare Inc.), 2007.
  34. Haldar C, Rai S, Singh R. Melatonin blocks dexamethasone-induced immunosuppression in a seasonally breeding rodent Indian palm squirrel, Funambulus pennanti. Steroids. 2004;69(6):367-377. https://doi.org/10.1016/j.steroids.2004.03.006
  35. Hamann GL, Campbell JD, George CM. Warfarin-cranberry juice interaction. Ann Pharmacother. 2011;45(3):e17. https://doi.org/10.1345/aph.1P451
  36. Han H-B, Chen J-Y, Yuan Y, Liang D-M, Zhang Y. The effect of cinobufacin combined with 5-FU on inhibiting proliferation and inducting apoptosis of human gastric carcinoma cells. Chinese Journal of General Surgery. 2006;9:4.
  37. Hashimoto S, Jing Y, Kawazoe N, Masuda Y, Nakajo S, Yoshida T, Kuroiwa Y, Nakaya K. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs. Leuk Res. 1997;21(9):875-883. https://doi.org/10.1016/S0145-2126(97)00061-1
  38. Haynes RB. Of studies, syntheses, synopses, summaries, and systems: the "5S" evolution of information services for evidence-based healthcare decisions. Evid Based Med. 2006;11(6):162-164.
  39. Hsiao WL, Liu L. The role of traditional Chinese herbal medicines in cancer therapy - from TCM theory to mechanistic insights. Planta Med. 2010;76(11):1118-1131. https://doi.org/10.1055/s-0030-1250186
  40. Hsu MJ, Lee SS, Lin WW. Polysaccharide purified from Ganoderma lucidum inhibits spontaneous and Fas-mediated apoptosis in human neutrophils through activation of the phosphatidylinositol 3 kinase/Akt signaling pathway. J Leukoc Biol. 2002;72(1):207-216.
  41. Huang KC. The Pharmacology of Chinese Herbs. 2nd Ed (Boca Raton, Florida: CRC Press), 1999.
  42. Hyodo I, Amano N, Eguchi K, Narabayashi M, Imanishi J, Hirai M, Nakano T, Takashima S. Nationwide survey on complementary and alternative medicine in cancer patients in Japan. J Clin Oncol. 2005;23(12):2645-2654. https://doi.org/10.1200/JCO.2005.04.126
  43. Janssen Inc. Yondelis (trabectedin) for injection [product information]. Toronto, Ontario; 2011.
  44. Jellin JM, Gregory PJ. Natural Medicines Comprehensive Database. 10th Ed (Stockton, CA: Therapeutic Research Faculty), 2007.
  45. Ji Z, Tang Q, Zhang J, Yang Y, Jia W, Pan Y. Immunomodulation of RAW264.7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. J Ethnopharmacol. 2007;112(3):445-450. https://doi.org/10.1016/j.jep.2007.03.035
  46. Jiang Y, Zhang Y, Luan J, Duan H, Zhang F, Yagasaki K, Zhang G. Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology. 2010;62(6):573-583. https://doi.org/10.1007/s10616-010-9310-0
  47. Kim KC, Jun HJ, Kim JS, Kim IG. Enhancement of radiation response with combined Ganoderma lucidum and Duchesnea chrysantha extracts in human leukemia HL-60 cells. Int J Mol Med. 2008;21(4):489-498.
  48. Kummervold PE, Chronaki CE, Lausen B, Prokosch H-U, Rasmussen J, Santana S, Staniszewski A, Wangberg SC. EHealth trends in Europe 2005-2007: a population-based survey. J Med Internet Res. 2008;10(4):e42. https://doi.org/10.2196/jmir.1023
  49. Lacy CF, Armstrong LL, Goldman MP, Lance LL. Drug Information Handbook with International Trade Names Index. 15th Ed (Hudson, OH: Lexi-comp Inc.), 2007-2008.
  50. Leja-Szpak A, Jaworek J, Pierzchalski P, Reiter RJ. Melatonin induces pro-apoptotic signaling pathway in human pancreatic carcinoma cells (PANC-1). J Pineal Res. 2010;49(3):248-255. https://doi.org/10.1111/j.1600-079X.2010.00789.x
  51. Li HY, Xu W, Zhang X, Zhang WD, Hu LW. Bufalin inhibits CYP3A4 activity in vitro and in vivo. Acta Pharmacol Sin. 2009;30(5):646-652. https://doi.org/10.1038/aps.2009.42
  52. Li YB, Wang R, Wu HL, Li YH, Zhong LJ, Yu HM, Li XJ. Serum amyloid A mediates the inhibitory effect of Ganoderma lucidum polysaccharides on tumor cell adhesion to endothelial cells. Oncol Rep. 2008;20(3):549-556.
  53. Lilja JJ, Backman JT, Neuvonen PJ. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam - probes of CYP2C9, CYP1A2, and CYP3A4. Clin Pharmacol Ther. 2007;81(6):833-839. https://doi.org/10.1038/sj.clpt.6100149
  54. Lim MK, Sadarangani P, Chan HL, Heng JY. Complementary and alternative medicine use in multiracial Singapore. Complement Ther Med. 2005;13(1):16-24. https://doi.org/10.1016/j.ctim.2004.11.002
  55. Lin KI, Kao YY, Kuo HK, Yang WB, Chou A, Lin HH, Yu AL, Wong CH. Reishi polysaccharides induce immunoglobulin production through the TLR4/TLR2-mediated induction of transcription factor Blimp-1. J Biol Chem. 2006;281(34):24111-24123. https://doi.org/10.1074/jbc.M601106200
  56. Lissoni P. Is there a role for melatonin in supportive care? Support Care Cancer. 2002;10(2):110-116. https://doi.org/10.1007/s005200100281
  57. Lissoni P, Barni S, Mandala M, Ardizzoia A, Paolorossi F, Vaghi M, Longarini R, Malugani F, Tancini G. Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer. 1999;35(12):1688-1692. https://doi.org/10.1016/S0959-8049(99)00159-8
  58. Lissoni P, Barni S, Tancini G, Rovelli F, Ardizzoia A, Conti A, Maestroni GJ. A study of the mechanisms involved in the immunostimulatory action of the pineal hormone in cancer patients. Oncology. 1993;50(6):399-402. https://doi.org/10.1159/000227218
  59. Lissoni P, Tancini G, Barni S, Paolorossi F, Ardizzoia A, Conti A, Maestroni G. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Support Care Cancer. 1997;5(2):126-129. https://doi.org/10.1007/BF01262569
  60. Macek C. East meets West to balance immunologic yin and yang. JAMA. 1984;251(4):433-435, 439. https://doi.org/10.1001/jama.1984.03340280003001
  61. Mansky PJ, Wallerstedt DB. Complementary medicine in palliative care and cancer symptom management. Cancer J. 2006;12:425-431. https://doi.org/10.1097/00130404-200609000-00011
  62. Mao T, van De Water J, Keem CL, Stern JS, Hackman R, Gershwin ME. Two mushrooms, Grifola frondosa and Ganoderma lucidum, can stimulate cytokine gene expression and proliferation in human T lymphocytes. Int J Immunother. 1999;15(1):13-22.
  63. Martin-Renedo J, Mauriz JL, Jorquera F, Ruiz-Andres O, Gonzalez P, Gonzalez-Gallego J. Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res. 2008;45(4):532-540. https://doi.org/10.1111/j.1600-079X.2008.00641.x
  64. Memorial Sloan-Kettering Cancer Center. Coenzyme Q10. http://www.mskcc.org/mskcc/html/69186.cfm. Accessed 12 September 2011.
  65. Meng Z, Yang P, Shen Y, Bei W, Zhang Y, Ge Y, Newman RA, Cohen L, Liu L, Thornton B, et al. Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer. 2009;115(22):5309-5318. https://doi.org/10.1002/cncr.24602
  66. Nahleh Z, Tabbara IA. Complementary and alternative medicine in breast cancer patients. Palliat Support Care. 2003;1(3):267-273.
  67. National Institutes of Health. Medline Plus Herbs and Supplements. http://www.nlm.nih.gov/medlineplus/druginfo/herb_All.html. Accessed 12 September 2011.
  68. National Institutes of Health, National Center for Complementary and Alternative Medicine. Health topics A-Z. http://nccam.nih.gov/health/atoz.htm. Accessed 12 September 2011.
  69. Neto CC, Amoroso JW, Liberty AM. Anticancer activities of cranberry phytochemicals: an update. Mol Nutr Food Res. 2008;52 Suppl 1:S18-27.
  70. Ngo N, Yan ZX, Graf TN, Carrizosa DR, Kashuba ADM, Dees EC, Oberlies NH, Paine MF. Identification of a cranberry juice product that inhibits enteric CYP3A-mediated first-pass metabolism in humans. Drug Metab Dispos. 2009;37(3):514-522. https://doi.org/10.1124/dmd.108.024968
  71. Oldendick R, Coker AL, Wieland D, Raymond JI, Probst JC, Schell BJ, Stoskopf CH. Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Carolina Complementary Medicine Program Baseline Research Team. South Med J. 2000;93:375-381. https://doi.org/10.1097/00007611-200093040-00005
  72. Ortiz-Lopez L, Morales-Mulia S, Ramirez-Rodriguez G, Benítez-King G. ROCK-regulated cytoskeletal dynamics participate in the inhibitory effect of melatonin on cancer cell migration. J Pineal Res. 2009;46(1):15-21. https://doi.org/10.1111/j.1600-079X.2008.00600.x
  73. OSI Pharmaceuticals Inc. Tarceva (erlotinib hydrochloride) tablets [product information]. Melville, NY; 2008.
  74. Paeng CH, Sprague M, Jackevicius CA. Interaction between warfarin and cranberry juice. Clin Ther. 2007;29(8):1730-1735. https://doi.org/10.1016/j.clinthera.2007.08.018
  75. Park JW, Hwang MS, Suh SI, Baek WK. Melatonin down-regulates HIF-1 alpha expression through inhibition of protein translation in prostate cancer cells. J Pineal Res. 2009;46(4):415-421. https://doi.org/10.1111/j.1600-079X.2009.00678.x
  76. Poon CH. Cancer drug database may protect patients. The Straits Times 2011;Sect. Home:B2. http://www.straitstimes.com/Singapore/Story/STIStory_707047 .html. Accessed 30 August 2011.
  77. Poon S, Poon J, Chan K, Loy C, Zhou X, Zhang R, Liu B, Kwan P, Sze D, Gao J. Analysis of synergistic and antagonistic effects of TCM: Cases on diabetes and insomnia: Paper presented at: IEEE International Conference on Bioinformatics and Biomedicine Workshops; 18 December, 2010; Hong Kong.
  78. Qi F, Li A, Inagaki Y, Kokudo N, Tamura S, Nakata M, Tang W. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor. Int Immunopharmacol. 2011;11(3):342-349. https://doi.org/10.1016/j.intimp.2010.12.007
  79. Qin TJ, Zhao XH, Yun J, Zhang LX, Ruan ZP, Pan BR. Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma. World J Gastroenterol. 2008;14(33):5210-5216. https://doi.org/10.3748/wjg.14.5210
  80. Raymond C. TCM Materia Medica (Chinese Herbal Database). http://www.tcmbasics.com/materiamedica.htm. Accessed 12 September 2011.
  81. Rootdown LLC. Rootdown.us - grow together (v2.187.423.57). http://www.rootdown.us/. Accessed 8 August 2009.
  82. Rosenfeldt FL, Haas SJ, Krum H, Hadj A, Ng K, Leong JY, Watts GF. Coenzyme Q10 in the treatment of hypertension: a meta-analysis of the clinical trials. J Hum Hypertens. 2007;21(4):297-306. https://doi.org/10.1038/sj.jhh.1002138
  83. Roxane Laboratories Inc. Cyclophosphamide tablets USP [product information]. Columbus, OH; 2007.
  84. Sagar SM, Wong RK. Chinese medicine and biomodulation in cancer patients - Part one. Curr Oncol. 2008;15(1):42-48. https://doi.org/10.3747/co.2008.197
  85. Seeram NP, Adams LS, Hardy ML, Heber D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J Agric Food Chem. 2004;52(9):2512-2517. https://doi.org/10.1021/jf0352778
  86. Shim M. Connecting internet use with gaps in cancer knowledge. Health Commun. 2008;23(5):448-461. https://doi.org/10.1080/10410230802342143
  87. Shinozawa S, Gomita Y, Araki Y. Tissue concentration of doxorubicin (adriamycin) in mouse pretreated with alpha-tocopherol or coenzyme Q10. Acta Med Okayama. 1991;45(3):195-199.
  88. Shinozawa S, Kawasaki H, Gomita Y. Effect of biological membrane stabilizing drugs (coenzyme Q10, dextran sulfate and reduced glutathione) on adriamycin (doxorubicin)-induced toxicity and microsomal lipid peroxidation in mice. Gan To Kagaku Ryoho. 1996;23(1):93-98.
  89. Sparreboom A, Cox MC, Acharya MR, Figg WD. Herbal remedies in the United States: potential adverse interactions with anticancer agents. J Clin Oncol. 2004;22:2489-2503. https://doi.org/10.1200/JCO.2004.08.182
  90. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol. 2002;9(3):1558-1562.
  91. Sun J, Hai Liu R. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer Lett. 2006;241(1):124-134. https://doi.org/10.1016/j.canlet.2005.10.027
  92. Suvarna R, Pirmohamed M, Henderson L. Possible interaction between warfarin and cranberry juice. BMJ. 2003;327(7429):1454. https://doi.org/10.1136/bmj.327.7429.1454
  93. Takai N, Ueda T, Nishida M, Nasu K, Narahara H. Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med. 2008;21(5):637-643.
  94. Tan KY, Liu CB, Chen AH, Ding YJ, Jin HY, Seow-Choen F. The role of traditional Chinese medicine in colorectal cancer treatment. Tech Coloproctol. 2008;12(1):1-6; discussion 6. https://doi.org/10.1007/s10151-008-0392-z
  95. Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncol. 2002;11(3):212-220. https://doi.org/10.1002/pon.552
  96. Tascilar M, de Jong FA, Verweij J, Mathijssen RHJ. Complementary and alternative medicine during cancer treatment: beyond innocence. Oncologist. 2006;11:732-741. https://doi.org/10.1634/theoncologist.11-7-732
  97. Thomson Healthcare. $Micromedex^{(R)}$ Healthcare Series [internet database]. http://www.micromedex.com. Accessed 3 February 2011.
  98. Trubiani O, Recchioni R, Moroni F, Pizzicannella J, Caputi S, Di Primio R. Melatonin provokes cell death in human B-lymphoma cells by mitochondrial-dependent apoptotic pathway activation. J Pineal Res. 2005;39(4):425-431. https://doi.org/10.1111/j.1600-079X.2005.00270.x
  99. Tsinghua Tongfang Knowledge Network Technology Co. Ltd. China National Knowledge Infrastructure (CNKI). http://en.cnki.com.cn/. Accessed 12 September 2011.
  100. Tsubaki K, Horiuchi A, Kitani T, Taniguchi N, Masaoka T, Shibata H, Yonezawa T, Tsubakio T, Kawagoe H, Shinohara Y, et al. Investigation of the preventive effect of CoQ10 against the side-effects of anthracycline antineoplastic agents. Gan To Kagaku Ryoho. 1984;11(7):1420-1427.
  101. Uesawa Y, Mohri K. Effects of cranberry juice on nifedipine pharmacokinetics in rats. J Pharm Pharmacol. 2006;58(8):1067-1072. https://doi.org/10.1211/jpp.58.8.0007
  102. Ulbricht C, Abrams TR, Bent S, Boon H, Costa D, Dacey C, Guilford J, Giese N, Serrano JMG, Hackman DA, et al. Reishi mushroom (Ganoderma lucidum): Systematic review by the natural standard research collaboration. J Soc Integr Oncol. 2010;8(4):148-159.
  103. Ushijima K, Koshimizu T-a, Fujimura A. The inhibitory effect of cranberry juice on phenytoin metabolism by human liver microsomes. Jap J Clin Pharmacol Ther. 2009a;40(2):59-64. https://doi.org/10.3999/jscpt.40.59
  104. Ushijima K, Tsuruoka S, Tsuda H, Hasegawa G, Obi Y, Kaneda T, Takahashi M, Maekawa T, Sasaki T, Koshimizu TA, et al. Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects. Br J Clin Pharmacol. 2009b;68(2):194-200. https://doi.org/10.1111/j.1365-2125.2009.03436.x
  105. Wachtel-Galor S, Szeto YT, Tomlinson B, Benzie IF. Ganoderma lucidum ('Lingzhi'); acute and short-term biomarker response to supplementation. Int J Food Sci Nutr. 2004a;55(1):75-83. https://doi.org/10.1080/09637480310001642510
  106. Wachtel-Galor S, Tomlinson B, Benzie IF. Ganoderma lucidum ("Lingzhi"), a Chinese medicinal mushroom: biomarker responses in a controlled human supplementation study. Br J Nutr. 2004b;91(2):263-269. https://doi.org/10.1079/BJN20041039
  107. Wang CZ, Basila D, Aung HH, Mehendale SR, Chang WT, McEntee E, Guan X, Yuan CS. Effects of ganoderma lucidum extract on chemotherapy-induced nausea and vomiting in a rat model. Am J Chin Med. 2005;33(5):807-815. https://doi.org/10.1142/S0192415X05003429
  108. Wang SY, Hsu ML, Hsu HC, Tzeng CH, Lee SS, Shiao MS, Ho CK. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. Int J Cancer. 1997;70(6):699-705. https://doi.org/10.1002/(SICI)1097-0215(19970317)70:6<699::AID-IJC12>3.0.CO;2-5
  109. Wang X, Zhao X, Li D, Lou YQ, Lin ZB, Zhang GL. Effects of Ganoderma lucidum polysaccharide on CYP2E1, CYP1A2 and CYP3A activities in BCG-immune hepatic injury in rats. Biol Pharm Bull. 2007;30(9):1702-1706. https://doi.org/10.1248/bpb.30.1702
  110. Welch JM, Forster K. Probable elevation in international normalized ratio from cranberry juice. J Pharm Technol. 2007;23(2):104-107. https://doi.org/10.1177/875512250702300207
  111. Weng CJ, Yen GC. The in vitro and in vivo experimental evidences disclose the chemopreventive effects of Ganoderma lucidum on cancer invasion and metastasis. Clin Exp Metastasis. 2010;27(5):361-369. https://doi.org/10.1007/s10585-010-9334-z
  112. White JD. The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer. J Altern Complement Med. 2002;8(5):545-550. https://doi.org/10.1089/107555302320825048
  113. Wong R, Sagar CM, Sagar SM. Integration of Chinese medicine into supportive cancer care: a modern role for an ancient tradition. Cancer Treat Rev. 2001;27(4):235-246. https://doi.org/10.1053/ctrv.2001.0227
  114. Wu W-Y, Chai X-S, Liu W-S. Synergistic anti-cancer effects and mechanisms of huachansu plus vinorelbine on Lewis lung cancer cell in mice. China Oncology. 2004;4:18.
  115. Xu X-Q. Study on the effects of Cinobufacin combined with taxol on murine S180 tumor in vivo. Strait Pharmaceutical Journal. 2009;2:8.
  116. Yang P, Chan D, Vijjeswarapu M, Cartwright C, Cohen L, Meng ZQ, Liu LM, Newman RA. Anti-proliferative activity of Huachansu, a Bufo toad skin extract, against human malignant melanoma cells: Paper presented at: American Association for Cancer Research, 2006.
  117. Yang P, Zhu X, Chan D, Cartwright C, Meng ZQ, Liu LM, Cohen L, Newman RA. Huachansu inhibits growth of human pancreatic cancer Panc-1 and BxPC3 xenograft tumors: Paper presented at: 99th American Association for Cancer Research (AACR) Annual Meeting, 2008; San Diego, CA.
  118. Yap KY-L, Chan A, Chui WK. Improving pharmaceutical care in oncology by pharmacoinformatics: the evolving role of informatics and the internet for drug therapy. Lancet Oncol. 2009a;10(10):1011-1019. https://doi.org/10.1016/S1470-2045(09)70104-4
  119. Yap KY-L, Chan A, Chui WK. Opinions on drug interaction sources in anticancer treatments and parameters for an oncology-specific database by pharmacy practitioners in Asia. Health Services Insights. 2010a;3:1-12.
  120. Yap KY-L, Chen YZ, Chui WK, Chan A. Oncoinformatics for the healthcare professional: oncology databases and blogs. Internet J Oncol. 2009b;6(1):1-22.
  121. Yap KY-L, Chuang X, Lee AJM, Lee RZ, Lim L, Lim JJ, Nimesha R. Pharmaco-cybernetics as an interactive component of pharma-culture: empowering drug knowledge through user-, experience- and activity-centered designs. Int J Comput Sci Issues. 2009c;3:1-13.
  122. Yap KY-L, See CS, Chan A. Clinically-relevant chemotherapy interactions with complementary and alternative medicines in patients with cancer. Recent Pat Food Nutr Agric. 2010b;2(1):12-55.
  123. Yap KY, Chui WK, Chan A. Drug interactions between chemotherapeutic regimens and antiepileptics. Clin Ther. 2008;30(8):1385-1407. https://doi.org/10.1016/j.clinthera.2008.08.011
  124. Yap KY, Kuo EY, Lee JJ, Chui WK, Chan A. An onco-informatics database for anticancer drug interactions with complementary and alternative medicines used in cancer treatment and supportive care: an overview of the OncoRx project. Support Care Cancer. 2010c;18(7):883-891. https://doi.org/10.1007/s00520-009-0729-9
  125. Yates JS, Mustian K, Morrow GR, Gillies LJ, Padmanaban D, Atkins JN, Issell B, Kirshner JJ, Colman LK. Prevalence of complementary and alternative medicine use in cancer patients during treatment. Support Care Cancer. 2005;13(10):806-811. https://doi.org/10.1007/s00520-004-0770-7
  126. Yu CH, Kan SF, Pu HF, Jea Chien E, Wang PS. Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci. 2008;99(12):2467-2476. https://doi.org/10.1111/j.1349-7006.2008.00966.x
  127. Yun HR, Yoo HS, Shin DY, Hong SH, Kim JH, Cho CK, Choi YH. Apoptosis induction of human lung carcinoma cells by Chan Su (Venenum Bufonis) through activation of caspases. J Acupunct Meridian Stud. 2009;2(3):210-217. https://doi.org/10.1016/S2005-2901(09)60057-1
  128. Zhang L, Li J-M, Wang Y, Shen Z-X. Apoptosis of monocytic leukemia cells induced by etoposide with the cooperation of cinobufacini. Journal of Internal Medicine Concepts and Practice 2007;2(2):12.
  129. Zhang L, Ma J, Pan K, Go VL, Chen J, You WC. Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial. Helicobacter. 2005;10(2):139-145. https://doi.org/10.1111/j.1523-5378.2005.00301.x
  130. Zhao S, Ye G, Fu G, Cheng JX, Yang BB, Peng C. Ganoderma lucidum exerts anti-tumor effects on ovarian cancer cells and enhances their sensitivity to cisplatin. Int J Oncol. 2011;38(5):1319-1327.
  131. Zhou J. New understanding of the basic theory of traditional Chinese medicine. Chin J Integr Med. 2009;15(1):7-12. https://doi.org/10.1007/s11655-009-0007-y
  132. Ziebland S, Chapple A, Dumelow C, Evans J, Prinjha S, Rozmovits L. How the internet affects patients' experience of cancer: a qualitative study. BMJ. 2004;328:564-569. https://doi.org/10.1136/bmj.328.7439.564
  133. Zikria J, Goldman R, Ansell J. Cranberry juice and warfarin: when bad publicity trumps science. Am J Med. 2010;123(5):384-392. https://doi.org/10.1016/j.amjmed.2009.08.019
  134. Zupancic D, Vidmar G, Jezernik K. Melatonin prevents the development of hyperplastic urothelium induced by repeated doses of cyclophosphamide. Virchows Arch. 2009;454(6):657-666. https://doi.org/10.1007/s00428-009-0765-3